๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells

โœ Scribed by J. Walewski; E. Paietta; J. Dutcher; P. H. Wiernik

Book ID
112295093
Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
489 KB
Volume
115
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Defective function of lymphokine-activat
Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma
โœ Toshiji Saibara; Saburo Onishi; Hiroshi Sakaeda; Yasutake Yamamoto ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 608 KB

Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i

Lack of correlation between peripheral b
Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2
โœ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t